Skip Navigation
Skip to contents

JYMS : Journal of Yeungnam Medical Science

Indexed in: ESCI, Scopus, PubMed,
PubMed Central, CAS, DOAJ, KCI
FREE article processing charge
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Prednisolone"
Filter
Filter
Article category
Keywords
Publication year
Authors
Case report
Anti-nuclear antibody-negative immunoglobulin G4-associated autoimmune hepatitis mimicking lymphoproliferative disorders
Min Kyu Kang, Jung Gil Park, Joon Hyuk Choi
Yeungnam Univ J Med. 2020;37(2):136-140.   Published online March 24, 2020
DOI: https://doi.org/10.12701/yujm.2020.00066
  • 4,849 View
  • 119 Download
  • 2 Crossref
AbstractAbstract PDF
Immunoglobulin G4 (IgG4)-associated autoimmune hepatitis (AIH) is a very rare subtype of autoimmune hepatitis and characterized by marked elevated serum IgG and hepatic infiltration of IgG4-expressing plasma cells. Pathologic confirmation of hepatic IgG4-expressing plasma cells is usually required for the final diagnosis of IgG4-associated AIH. Herein, we report the case of a 47-year-old female diagnosed with autoantibody-negative IgG4-associated AIH mimicking lymphoproliferative disorders.

Citations

Citations to this article as recorded by  
  • Hepatic Involvement of Diffuse Large B-Cell Lymphoma Mimicking Antinuclear Antibody-Negative Autoimmune Hepatitis Diagnosed by Liver Biopsy
    Euna Lee, Min-Kyu Kang, Gabin Moon, Mi-Jin Gu
    Medicina.2022; 59(1): 77.     CrossRef
  • Immunoglobulin G4 (IgG4)‐related autoimmune hepatitis and IgG4‐hepatopathy: A histopathological and clinical perspective
    Atsushi Tanaka, Kenji Notohara
    Hepatology Research.2021; 51(8): 850.     CrossRef
Case Report
Treatment of Hemangiopericytoma-Associated Hypoglycemia with Glucocorticoid Therapy.
Sung Woo Park, Dong Geun Kim, Myung Jin Kim, Hyo Jin Jang, Se Hoon Sohn, Sung Ae Koh, Ha Young Lee, Min Kyoung Kim, Kyoung Hee Lee, Myung Soo Hyun
Yeungnam Univ J Med. 2011;28(1):77-83.   Published online June 30, 2011
DOI: https://doi.org/10.12701/yujm.2011.28.1.77
  • 1,674 View
  • 1 Download
AbstractAbstract PDF
Non-islet cell tumor-induced hypoglycemia (NICTH) is associated with mesenchymal tumor types, including hemangiopericytoma, fibrosarcoma, mesothelioma, and neurofibroma, as well as carcinoma of the liver, adrenal glands, and kidneys. Non-islet cell tumors induce hypoglycemia by overproducing an abnormal form of insulin-like growth factor II (IGF II). Complete removal of the tumor or reduction of the tumor mass is a successful therapeutic strategy in cases of NICTH. However, if the tumor re-grows, curative resection is nearly impossible, and hypoglycemia occurs repeatedly. Glucocorticoids are effective in terms of long-term relief from hypoglycemia through promotion of gluconeogenesis in the liver, tumor suppression, production of 'big'-IGF-II, and correction of the attendant biochemical abnormalities involving the growth hormone (GH)-IGF axis. We found that administration of corticosteroid therapy to a patient suffering from NICTH resulted in improvement of hypoglycemia associated symptoms.

JYMS : Journal of Yeungnam Medical Science